LBX Pharmacy Chain JSC banner

LBX Pharmacy Chain JSC
SSE:603883

Watchlist Manager
LBX Pharmacy Chain JSC Logo
LBX Pharmacy Chain JSC
SSE:603883
Watchlist
Price: 14 CNY -0.78% Market Closed
Market Cap: ¥10.6B

LBX Pharmacy Chain JSC
Net Issuance of Debt

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

LBX Pharmacy Chain JSC
Net Issuance of Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Debt CAGR 3Y CAGR 5Y CAGR 10Y
LBX Pharmacy Chain JSC
SSE:603883
Net Issuance of Debt
-¥461.5m
CAGR 3-Years
-63%
CAGR 5-Years
-59%
CAGR 10-Years
-20%
D
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Net Issuance of Debt
-¥1.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yifeng Pharmacy Chain Co Ltd
SSE:603939
Net Issuance of Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
Net Issuance of Debt
¥155.3m
CAGR 3-Years
-31%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
Net Issuance of Debt
¥170.3m
CAGR 3-Years
-43%
CAGR 5-Years
N/A
CAGR 10-Years
-12%
A
Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408
Net Issuance of Debt
-¥67.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

LBX Pharmacy Chain JSC
Glance View

Market Cap
10.6B CNY
Industry
Retail

LBX Pharmacy Chain JSC has emerged as a significant player in the pharmaceutical retail sector in China, riding the wave of increasing health consciousness and the aging population. Founded in a fast-paced, constantly evolving market, the company has strategically positioned itself to leverage this demographic shift. Its primary business model revolves around operating an extensive network of pharmacy outlets that serve both urban and rural customers. By offering a wide range of products, from prescription medications to health supplements and wellness goods, LBX ensures it caters to a diverse clientele, satisfying varying health care needs. The implementation of an omnichannel approach, integrating online and offline sales, has not only enhanced customer convenience but also expanded its reach, reinforcing its market position. Central to LBX’s profitability is its efficient supply chain management and strategic location of stores in high-traffic areas, which augments its accessibility and stock management capabilities. The company leverages partnerships with leading pharmaceutical manufacturers and distributors, securing competitive pricing and product availability. Additionally, its investment in technology bolsters its operational efficiency, enabling real-time inventory tracking and personalized customer service. This tech-driven approach enhances customer loyalty and provides insights into consumer behavior, guiding strategic decisions. Through a well-crafted blend of traditional retail expertise and innovative solutions, LBX Pharmacy Chain JSC continues to solidify its foothold in the market, driving revenue growth and expanding its reach across China.

Intrinsic Value
31.07 CNY
Undervaluation 55%
Intrinsic Value
Price ¥14

See Also

What is LBX Pharmacy Chain JSC's Net Issuance of Debt?
Net Issuance of Debt
-461.5m CNY

Based on the financial report for Mar 31, 2026, LBX Pharmacy Chain JSC's Net Issuance of Debt amounts to -461.5m CNY.

What is LBX Pharmacy Chain JSC's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 10Y
-20%

The average annual Net Issuance of Debt growth rates for LBX Pharmacy Chain JSC have been -63% over the past three years , -59% over the past five years , and -20% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett